Response to: "Rescuing the NIH before it is too late"
نویسندگان
چکیده
منابع مشابه
Rescuing the NIH before it is too late.
In the Coen brothers' The Big Lebowski the hero, who calls himself "The Dude," has just had his apartment broken into by some dumb thugs. One of the thugs lifts the Dude's prized bowling ball and says, "What . . . is this?" The Dude replies, "Obviously you are not a golfer." The current state of the NIH prompts me to say to its director, Dr. Elias Zerhouni, "Obviously you are not a scientist."
متن کاملResponse to: "Rescuing the NIH before it is too late" from the Deputy Director for Extramural Research.
For a number of reasons, the NIH and the biomedical research community are facing a period of fiscal constraint after pronounced growth. In these difficult times, it is important that we all speak from the facts and work together to do a better job of explaining the importance of the nation's investment in biomedical research.
متن کاملSearching for Life on Mars Before It Is Too Late
Decades of robotic exploration have confirmed that in the distant past, Mars was warmer and wetter and its surface was habitable. However, none of the spacecraft missions to Mars have included among their scientific objectives the exploration of Special Regions, those places on the planet that could be inhabited by extant martian life or where terrestrial microorganisms might replicate. A major...
متن کاملIs it too late to treat me?
We present the case of a 76-year-old Caucasian man with a type 1 endoleak at the proximal edge of a thoracic stentgraft (Talent 38 mm × 114 mm) detected four years after endovascular treatment of a large symptomatic saccular aneurysm in the distal aortic arch. The patient refused any interventional treatment for the endoleak and remained on medical therapy with no evolving symptoms. Surveillanc...
متن کاملBefore it is too late: professional responsibilities in late-onset Alzheimer’s research and pre-symptomatic prediction
The development of a wide array of molecular and neuroscientific biomarkers can provide the possibility to visualize the course of Alzheimer's disease (AD) at early stages. Many of these biomarkers are aimed at detecting not only a preclinical, but also a pre-symptomatic state. They are supposed to facilitate clinical trials aiming at treatments that attack the disease at its earliest stage or ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Investigation
سال: 2006
ISSN: 0021-9738
DOI: 10.1172/jci28894